Adoptive-cell-transfer therapy for the treatment of patients with cancer

Mark E. Dudley, Steven A. Rosenberg

Research output: Contribution to journalReview articlepeer-review

500 Scopus citations


Adoptive immunotherapy - the isolation of antigen-specific cells, their ex vivo expansion and activation, and subsequent autologous administration - is a promising approach to inducing antitumour immune responses. The molecular identification of tumour antigens and the ability to monitor the persistence and transport of transferred cells has provided new insights into the mechanisms of tumour immunotherapy. Recent studies have shown the effectiveness of cell-transfer therapies for the treatment of patients with selected metastatic cancers. These studies provide a blueprint for the wider application of adoptive-cell-transfer therapy, and emphasize the requirement for in vivo persistence of the cells for therapeutic efficacy.

Original languageEnglish (US)
Pages (from-to)666-675
Number of pages10
JournalNature Reviews Cancer
Issue number9
StatePublished - Sep 2003
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Adoptive-cell-transfer therapy for the treatment of patients with cancer'. Together they form a unique fingerprint.

Cite this